Monday, June 22, 2026

Wang Yi of China Meets North Korean Delegation, Stresses ‘Need for Enhanced Strategic Communication and Tactical Cooperation Between the Two Nations’

A North Korean Workers' Party delegation visiting...

THE NEXT CALIBER : Why Kim Jong Un Is Handing The Weapon To His Successor Now

Kim Jong Un inspected a munitions factory, emphasizing modernization and new production lines for enhancing military capabilities.

BlackRock Acquires 5.01% Stake in HLB: What This Means for Investors

BlackRock acquires a 5.01% stake in HLB, becoming the second-largest shareholder, signaling confidence in HLB's liver cancer drug.

Tag: EMA

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Sam Chun Dang Pharm Wins EMA Approval for Phase 1 Trial of Oral Insulin Candidate SCD0503

Samchundang Pharmaceutical's oral insulin candidate 'SCD0503' received final approval for Phase 1 clinical trials from EMA.

A 90-Minute Cancer Infusion Could Soon Be Cut to 5 Minutes—and Celltrion Wants to Lead It

Celltrion has applied for EMA approval of Herzuma SC, a new breast cancer treatment, enhancing drug delivery and patient convenience.

CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in Europe

Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.